154 related articles for article (PubMed ID: 37806747)
1. Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4-oxadiazole derivatives: Synthesis, in vitro screening, and computational studies.
Fatima B; Saleem F; Salar U; Chigurupati S; Felemban SG; Ul-Haq Z; Tariq SS; Almahmoud SA; Taha M; Shah STA; Khan KM
Arch Pharm (Weinheim); 2023 Dec; 356(12):e2300384. PubMed ID: 37806747
[TBL] [Abstract][Full Text] [Related]
2. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
3. In Vitro and Molecular Docking Evaluation of the Anticholinesterase and Antidiabetic Effects of Compounds from
Feunaing RT; Tamfu AN; Gbaweng AJY; Kucukaydin S; Tchamgoue J; Lannang AM; Lenta BN; Kouam SF; Duru ME; Anouar EH; Talla E; Dinica RM
Molecules; 2024 May; 29(11):. PubMed ID: 38893333
[TBL] [Abstract][Full Text] [Related]
4. Bioevaluation of synthetic pyridones as dual inhibitors of α-amylase and α-glucosidase enzymes and potential antioxidants.
Saleem F; Khan KM; Ullah N; Özil M; Baltaş N; Hameed S; Salar U; Wadood A; Rehman AU; Kumar M; Taha M; Haider SM
Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200400. PubMed ID: 36284484
[TBL] [Abstract][Full Text] [Related]
5. Comparative Cholinesterase, α-Glucosidase Inhibitory, Antioxidant, Molecular Docking, and Kinetic Studies on Potent Succinimide Derivatives.
Ahmad A; Ullah F; Sadiq A; Ayaz M; Saeed Jan M; Shahid M; Wadood A; Mahmood F; Rashid U; Ullah R; Sahibzada MUK; Alqahtani AS; Mahmood HM
Drug Des Devel Ther; 2020; 14():2165-2178. PubMed ID: 32606589
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of synthetic 2-aryl quinoxaline derivatives as α-amylase, α-glucosidase, acetylcholinesterase, and butyrylcholinesterase inhibitors.
Hameed S; Khan KM; Taslimi P; Salar U; Taskin-Tok T; Kisa D; Saleem F; Solangi M; Ahmed MHU; Rani K
Int J Biol Macromol; 2022 Jun; 211():653-668. PubMed ID: 35568155
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and screening of (E)-3-(2-benzylidenehydrazinyl)-5,6-diphenyl-1,2,4-triazine analogs as novel dual inhibitors of α-amylase and α-glucosidase.
Shamim S; Khan KM; Ullah N; Chigurupati S; Wadood A; Ur Rehman A; Ali M; Salar U; Alhowail A; Taha M; Perveen S
Bioorg Chem; 2020 Aug; 101():103979. PubMed ID: 32544738
[TBL] [Abstract][Full Text] [Related]
8.
Metiefeng NT; Tamfu AN; Fotsing Tagatsing M; Tabopda TK; Kucukaydin S; Noah Mbane M; de Theodore Atchade A; Talla E; Henoumont C; Laurent S; Anouar EH; Dinica RM
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375357
[No Abstract] [Full Text] [Related]
9. New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents.
Acar Çevik U; Celik I; Paşayeva L; Fatullayev H; Bostancı HE; Özkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2023 May; 356(5):e2200663. PubMed ID: 36760015
[TBL] [Abstract][Full Text] [Related]
10. Efficient one-pot synthesis of arylated pyrazole-fused pyran analogs: as leads to treating diabetes and Alzheimer's disease.
Hameed S; Babatunde O; Salar U; Jabbar A; Chigurupati S; Solangi M; Atta L; Ul-Haq Z; Saleem F; Bhatia S; Al-Harrasi A; Taha M; Khan KM
Future Med Chem; 2022 Nov; 14(21):1507-1526. PubMed ID: 36268762
[No Abstract] [Full Text] [Related]
11. Synthesis of novel 5-(2,5-bis(2,2,2-trifluoroethoxy)phenyl)-1,3,4-oxadiazole-2-thiol derivatives as potential glucosidase inhibitors.
Gani RS; Kudva AK; Timanagouda K; Raghuveer ; Mujawar SBH; Joshi SD; Raghu SV
Bioorg Chem; 2021 Sep; 114():105046. PubMed ID: 34126575
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
Tripathi A; Choubey PK; Sharma P; Seth A; Saraf P; Shrivastava SK
Bioorg Chem; 2020 Jan; 95():103506. PubMed ID: 31887472
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
[TBL] [Abstract][Full Text] [Related]
14.
Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in Vitro Cholinesterase Inhibition, Molecular Docking, DFT, and ADME Studies of Novel 1,3,4-Oxadiazole-2-Thiol Derivatives.
Tariq S; Mutahir S; Khan MA; Mutahir Z; Hussain S; Ashraf M; Bao X; Zhou B; Stark CBW; Khan IU
Chem Biodivers; 2022 Aug; 19(8):e202200157. PubMed ID: 35767725
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and bioactivities evaluation of oleanolic acid oxime ester derivatives as
Deng XY; Ke JJ; Zheng YY; Li DL; Zhang K; Zheng X; Wu JY; Xiong Z; Wu PP; Xu XT
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):451-461. PubMed ID: 35012401
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies.
Saleem F; Kanwal ; Khan KM; Chigurupati S; Solangi M; Nemala AR; Mushtaq M; Ul-Haq Z; Taha M; Perveen S
Bioorg Chem; 2021 Jan; 106():104489. PubMed ID: 33272713
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study.
Hussain R; Iqbal S; Shah M; Rehman W; Khan S; Rasheed L; Rahim F; Dera AA; Kehili S; Elkaeed EB; Awwad NS; Bajaber MA; Alahmdi MI; Alrbyawi H; Alsaab HO
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234994
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, In vitro α-Glucosidase Inhibitory Potential and Molecular Docking Studies of 2-Amino-1,3,4-Oxadiazole Derivatives.
Ullah H; Rahim F; Taha M; Hussain R; Wadood A; Nawaz M; Wahab Z; Kanwal ; Khan KM
Med Chem; 2020; 16(6):724-734. PubMed ID: 31195948
[TBL] [Abstract][Full Text] [Related]
20. Novel cinnamic acid magnolol derivatives as potent α-glucosidase and α-amylase inhibitors: Synthesis, in vitro and in silico studies.
Hu CM; Wang WJ; Ye YN; Kang Y; Lin J; Wu PP; Li DL; Bai LP; Xu XT; Li BQ; Zhang K
Bioorg Chem; 2021 Nov; 116():105291. PubMed ID: 34438122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
